Bio-Techne (TECH) Enterprise Value (2009 - 2026)
Bio-Techne (TECH) recorded quarterly Enterprise Value of -$209.8 million in Q1 2026, down 21.37% quarter-over-quarter from -$172.9 million in Q4 2025, and down 49.16% on a YoY basis from -$412.7 million in Q1 2025.
Bio-Techne (TECH) Enterprise Value (2009 - 2026) Analysis & Trends
Bio-Techne's Enterprise Value history runs 18 years deep, the most recent figure standing at -$209.8 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 49.16% year-over-year to -$209.8 million; the TTM figure through Mar 2026 stood at -$209.8 million (down 49.16% YoY), while the FY2025 annual figure was -$165.0 million, down 2.12% from the prior year.
- Enterprise Value was -$209.8 million for Q1 2026 at Bio-Techne, down from -$172.9 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$135.7 million in Q4 2023 to a low of -$247.8 million in Q2 2022.
- Historically, Enterprise Value has averaged -$179.5 million across 5 years, with a median of -$172.9 million in 2025.
- The sharpest annual moves came in 2023 and 2026: Enterprise Value soared 32.31% in 2023, then tumbled 49.16% in 2026.
- A 5-year view of Enterprise Value shows it stood at -$196.8 million in 2022, then soared by 31.06% to -$135.7 million in 2023, then sank by 33.26% to -$180.8 million in 2024, then rose by 4.37% to -$172.9 million in 2025, then dropped by 21.37% to -$209.8 million in 2026.
- The last three Enterprise Value figures came in at -$209.8 million (Q1 2026), -$172.9 million (Q4 2025), and -$145.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn | -209.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -209.82 Mn |
| Dec 31, 2025 | -172.88 Mn |
| Sep 30, 2025 | -144.96 Mn |
| Jun 30, 2025 | -165.03 Mn |
| Mar 31, 2025 | -140.67 Mn |
| Dec 31, 2024 | -180.78 Mn |
| Sep 30, 2024 | -194.21 Mn |
| Jun 30, 2024 | -161.60 Mn |
| Mar 31, 2024 | -145.31 Mn |
| Dec 31, 2023 | -135.65 Mn |
| Sep 30, 2023 | -166.15 Mn |
| Jun 30, 2023 | -197.43 Mn |
| Mar 31, 2023 | -157.20 Mn |
| Dec 31, 2022 | -196.76 Mn |
| Sep 30, 2022 | -203.08 Mn |
| Jun 30, 2022 | -247.79 Mn |
| Mar 31, 2022 | -232.23 Mn |
| Dec 31, 2021 | -279.44 Mn |
| Sep 30, 2021 | -227.47 Mn |
| Jun 30, 2021 | -223.29 Mn |